Search Results - "Sádaba, B"

Refine Results
  1. 1

    A phase I clinical trial of thymidine kinase-based gene therapy in advanced hepatocellular carcinoma by Sangro, B, Mazzolini, G, Ruiz, M, Ruiz, J, Quiroga, J, Herrero, I, Qian, C, Benito, A, Larrache, J, Olagüe, C, Boan, J, Peñuelas, I, Sádaba, B, Prieto, J

    Published in Cancer gene therapy (01-12-2010)
    “…The aim of this phase I clinical trial was to assess the feasibility and safety of intratumoral administration of a first-generation adenoviral vector encoding…”
    Get full text
    Journal Article
  2. 2

    Monoclonal antibodies: Pharmacokinetics as a basis for new dosage regimens? by Azanza, J-R, Sádaba, B, Gómez-Guiu, A

    Published in Journal of Oncology Pharmacy Practice (01-10-2015)
    “…Complete monoclonal IgG antibodies which are in use in clinical practice share some pharmacological properties resulting in high concentrations in plasma. This…”
    Get full text
    Book Review Journal Article
  3. 3

    Oral Availability of Bilastine by Sádaba, B., Gómez-Guiu, A., Azanza, J. R., Ortega, I., Valiente, R.

    Published in Clinical drug investigation (01-05-2013)
    “…Background and Objective Bilastine (Bilaxten™) is a novel non-sedating H 1 receptor antagonist (antihistamine) developed in the dosage form of oral tablets and…”
    Get full text
    Journal Article
  4. 4

    Clinical relevance of sirolimus drug interactions in transplant patients by Sádaba, B., Campanero, M.A., Quetglas, E.G., Azanza, J.R.

    Published in Transplantation proceedings (01-12-2004)
    “…Sirolimus, a new immunosuppressant drug; is metabolized by cytochrome P450 3A4 (CYP3A4) and is a substrate of the P-glycoprotein drug efflux pump. The…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Aflibercept. Una aproximación a la farmacología by Azanza Perea, J.R, Sádaba, B

    “…Resumen Aflibercept es una proteina de fusion que combina en su estructura quimica, la fraccion constante de cualquier IgG con una fraccion variable construida…”
    Get full text
    Journal Article
  7. 7

    Relationship between pharmacokinetics and pharmacodynamics of β‐lactams and outcome by Sádaba, B., Azanza, J. R., Campanero, M. A., García‐Quetglas, E.

    Published in Clinical microbiology and infection (01-11-2004)
    “…The in‐vitro susceptibility of an organism and the pharmacokinetics of an antimicrobial agent are two basic factors on which the choice of standardised…”
    Get full text
    Journal Article
  8. 8

    Diversity and Screening of Cellulolytic Microorganisms from Mangrove Forests, Natural Parks, Paddy Field, and Sugarcane Plantation in Panay Island, Philippines by Gatpatan, Isabel Grace T, Cabulong, Rhudith B, Sadaba, Resurreccion B

    “…Cellulolytic microorganisms secrete cellulase, which plays a crucial role in the conversion of lignocellulosic biomass into value-added products with diverse…”
    Get full text
    Journal Article
  9. 9

    Fungal diversity of mangrove-associated sponges from New Washington, Aklan, Philippines by Calabon, Mark S., Sadaba, Resurreccion B., Campos, Wilfredo L.

    Published in Mycology (02-01-2019)
    “…Sponge-associated fungi are the least explored marine fungal groups. It is only in recent years that fungal symbionts of marine sponges have received attention…”
    Get full text
    Journal Article
  10. 10

    Concurrent clarithromycin and cyclosporin A treatment by SADABA, B, LOPEZ DE OCARIZ, A, AZANZA, J. R, QUIROGA, J, CIENFUEGOS, J. A

    Published in Journal of antimicrobial chemotherapy (01-09-1998)
    “…Although macrolides have been associated with significant pharmacokinetic interactions, clarithromycin is considered to have a low interaction capacity. In…”
    Get full text
    Journal Article
  11. 11

    Rapid high-performance liquid chromatographic determination of cefepime in human plasma by Calahorra, B., Campanero, M. A., Sádaba, B., Azanza, J. R.

    Published in Biomedical chromatography (01-06-1999)
    “…A simple, rapid and reproducible high‐performance liquid chromatographic method for the quantitative determination of cefepime in human plasma was developed…”
    Get full text
    Journal Article
  12. 12

    Oral versus intravenous therapy in the treatment of systemic mycosis by Perea, J.R. Azanza, Díaz de Rada, B. Sádaba, Quetglas, E. García, Juarez, M.J. Muñóz

    Published in Clinical microbiology and infection (01-03-2004)
    “…The great majority of systemic fungal infections require long-term therapy that often extends 6–12 months, particularly in immunosuppressed patients. It can be…”
    Get full text
    Journal Article
  13. 13

    Development of a chromatographic method for the determination of saquinavir in plasma samples of HIV patients by Campanero, M. A., Escolar, M., Arangoa, M. A., Sádaba, B., Azanza, J. R.

    Published in Biomedical chromatography (01-02-2002)
    “…A simple, sensitive and reproducible high‐performance liquid chromatographic method for detecting and quantifying saquinavir in human plasma is described…”
    Get full text
    Journal Article
  14. 14

    Pharmacokinetics of tramadol enantiomers and their respective phase I metabolites in relation to CYP2D6 phenotype by García-Quetglas, Emilio, Azanza, José Ramón, Sádaba, Belén, Muñoz, María José, Gil, Isabel, Campanero, Miguel Angel

    Published in Pharmacological research (01-02-2007)
    “…Our objective was to evaluate the effect of CYP2D6 phenotype in the enantioselective metabolism of tramadol in Spanish healthy human volunteers. A single oral…”
    Get full text
    Journal Article
  15. 15

    Bioavailability of two oral fentanyl transmucosal formulations in healthy volunteers: and open-label, crossover, randomised study by SADABA DIAZ DE RADA, BELEN, Gómez-Guiu Hormigos, Almudena, Roset Arissó, Pere, Azanza Perea, José Ramón, Goñi Allo, Beatriz

    “…ABSTRACT Introduction: Oral transmucosal fentanyl citrate (OTFC) was the first product specifically designed for the treatment of breakthrough pain. It is…”
    Get full text
    Journal Article
  16. 16
  17. 17
  18. 18

    Simultaneous stereoselective analysis of tramadol and its primary phase I metabolites in plasma by liquid chromatography: Application to a pharmacokinetic study in humans by Campanero, Miguel Angel, Garcı́a-Quetglas, Emilio, Sádaba, Belén, Azanza, Jose Ramón

    Published in Journal of Chromatography A (26-03-2004)
    “…This paper describes a bioanalytical method involving a simple liquid–liquid extraction for the simultaneous HPLC determination of the enantiomers of tramadol,…”
    Get full text
    Journal Article Conference Proceeding
  19. 19

    Detection and incidence of drug-induced agranulocytosis in hospital : a prospective analysis from laboratory signals by TAVASSOLI, N, DUCHAYNE, E, BAGHERI, H, SADABA, B, DESBOEUF, K, SOMMET, A, LAPEYRE-MESTRE, M, MUOZ, M. J, SIE, P, HONORATO, MONTASTRUC, J. L

    Published in European journal of clinical pharmacology (01-03-2007)
    “…Our objectives were to assess the detection and incidence of drug-induced agranulocytosis in two university hospitals using hematology laboratory data. A…”
    Get full text
    Journal Article
  20. 20

    Aflibercept. An approach to pharmacology by Azanza Perea, J R, Sádaba, B

    “…Aflibercept is a fusion protein whose chemical structure combines the constant fraction of any IgG with a variable fraction constructed with fundamental parts…”
    Get full text
    Journal Article